119 related articles for article (PubMed ID: 11823715)
1. Inhibition of cyclin-dependent kinases improves CA1 neuronal survival and behavioral performance after global ischemia in the rat.
Wang F; Corbett D; Osuga H; Osuga S; Ikeda JE; Slack RS; Hogan MJ; Hakim AM; Park DS
J Cereb Blood Flow Metab; 2002 Feb; 22(2):171-82. PubMed ID: 11823715
[TBL] [Abstract][Full Text] [Related]
2. Delayed combinatorial treatment with flavopiridol and minocycline provides longer term protection for neuronal soma but not dendrites following global ischemia.
Iyirhiaro GO; Brust TB; Rashidian J; Galehdar Z; Osman A; Phillips M; Slack RS; Macvicar BA; Park DS
J Neurochem; 2008 May; 105(3):703-13. PubMed ID: 18205749
[TBL] [Abstract][Full Text] [Related]
3. The cyclin-dependent kinase (CDK) inhibitor flavopiridol inhibits glycogen phosphorylase.
Kaiser A; Nishi K; Gorin FA; Walsh DA; Bradbury EM; Schnier JB
Arch Biochem Biophys; 2001 Feb; 386(2):179-87. PubMed ID: 11368340
[TBL] [Abstract][Full Text] [Related]
4. The neuroprotective effects of K252a through inhibiting MLK3/MKK7/JNK3 signaling pathway on ischemic brain injury in rat hippocampal CA1 region.
Pan J; Zhang QG; Zhang GY
Neuroscience; 2005; 131(1):147-59. PubMed ID: 15680699
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of neuronal apoptosis by the cyclin-dependent kinase inhibitor GW8510: identification of 3' substituted indolones as a scaffold for the development of neuroprotective drugs.
Johnson K; Liu L; Majdzadeh N; Chavez C; Chin PC; Morrison B; Wang L; Park J; Chugh P; Chen HM; D'Mello SR
J Neurochem; 2005 May; 93(3):538-48. PubMed ID: 15836613
[TBL] [Abstract][Full Text] [Related]
6. In vivo administration of corticotropin-releasing hormone at remote intervals following ischemia enhances CA1 neuronal survival and recovery of spatial memory impairments: a role for opioid receptors.
Charron C; Fréchette S; Proulx G; Plamondon H
Behav Brain Res; 2008 Mar; 188(1):125-35. PubMed ID: 18055027
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cell cycle pathway by flavopiridol promotes survival of cerebellar granule cells after an excitotoxic treatment.
Verdaguer E; Jiménez A; Canudas AM; Jordà EG; Sureda FX; Pallàs M; Camins A
J Pharmacol Exp Ther; 2004 Feb; 308(2):609-16. PubMed ID: 14610234
[TBL] [Abstract][Full Text] [Related]
8. The cyclin-dependent kinase inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis in colon and gastric cancer cells.
Jung C; Motwani M; Kortmansky J; Sirotnak FM; She Y; Gonen M; Haimovitz-Friedman A; Schwartz GK
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6052-61. PubMed ID: 14676132
[TBL] [Abstract][Full Text] [Related]
9. Rhabdoid tumor growth is inhibited by flavopiridol.
Smith ME; Cimica V; Chinni S; Challagulla K; Mani S; Kalpana GV
Clin Cancer Res; 2008 Jan; 14(2):523-32. PubMed ID: 18223228
[TBL] [Abstract][Full Text] [Related]
10. Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases.
Raju U; Ariga H; Koto M; Lu X; Pickett J; Valdecanas D; Mason KA; Milas L
Radiother Oncol; 2006 Aug; 80(2):185-91. PubMed ID: 16905211
[TBL] [Abstract][Full Text] [Related]
11. The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1.
Gojo I; Zhang B; Fenton RG
Clin Cancer Res; 2002 Nov; 8(11):3527-38. PubMed ID: 12429644
[TBL] [Abstract][Full Text] [Related]
12. PP2, a potent inhibitor of Src family kinases, protects against hippocampal CA1 pyramidal cell death after transient global brain ischemia.
Hou XY; Liu Y; Zhang GY
Neurosci Lett; 2007 Jun; 420(3):235-9. PubMed ID: 17556100
[TBL] [Abstract][Full Text] [Related]
13. Flavopiridol, an inhibitor of cyclin-dependent kinases, induces growth inhibition and apoptosis in bladder cancer cells in vitro and in vivo.
Wirger A; Perabo FG; Burgemeister S; Haase L; Schmidt DH; Doehn C; Mueller SC; Jocham D
Anticancer Res; 2005; 25(6B):4341-7. PubMed ID: 16309238
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for inhibition of cyclin-dependent kinase 9 by flavopiridol.
de Azevedo WF; Canduri F; da Silveira NJ
Biochem Biophys Res Commun; 2002 Apr; 293(1):566-71. PubMed ID: 12054639
[TBL] [Abstract][Full Text] [Related]
15. Cerebral ischemic preconditioning induces lasting effects on CA1 neuronal survival, prevents memory impairments but not ischemia-induced hyperactivity.
Plamondon H; Davignon G; Khan S; Charron C
Behav Brain Res; 2008 May; 189(1):145-51. PubMed ID: 18281106
[TBL] [Abstract][Full Text] [Related]
16. Lithium regulates hippocampal neurogenesis by ERK pathway and facilitates recovery of spatial learning and memory in rats after transient global cerebral ischemia.
Yan XB; Hou HL; Wu LM; Liu J; Zhou JN
Neuropharmacology; 2007 Sep; 53(4):487-95. PubMed ID: 17686496
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis and down regulation of cell cycle proteins in mantle cell lymphoma by flavopiridol treatment.
Venkataraman G; Maududi T; Ozpuyan F; Bahar HI; Izban KF; Qin JZ; Alkan S
Leuk Res; 2006 Nov; 30(11):1377-84. PubMed ID: 16624404
[TBL] [Abstract][Full Text] [Related]
18. Profound but transient deficits in learning and memory after global ischemia using a novel water maze test.
von Euler M; Bendel O; Bueters T; Sandin J; von Euler G
Behav Brain Res; 2006 Jan; 166(2):204-10. PubMed ID: 16159675
[TBL] [Abstract][Full Text] [Related]
19. [Effects of Capsule Yizhi on the delayed neuronal death in hippocampal CA1 region and memory function after global cerebral ischemia in rats].
Li L; Wang W; Wu H; Sun L; Xu J
Zhong Yao Cai; 2004 Jul; 27(7):506-9. PubMed ID: 15551967
[TBL] [Abstract][Full Text] [Related]
20. Subtoxic N-methyl-D-aspartate delayed neuronal death in ischemic brain injury through TrkB receptor- and calmodulin-mediated PI-3K/Akt pathway activation.
Xu J; Zhang QG; Li C; Zhang GY
Hippocampus; 2007; 17(7):525-37. PubMed ID: 17492691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
